Navigation Links
Stem Cell Therapy for Premature Ovarian Failure (POF)

BEIJING, Jan. 9, 2014 /PRNewswire/ -- Premature ovarian failure (POF) is an illness seen in women under 40 years old who suffer from amenorrhea. Their blood level FSH stays over 40IU/L, with E2 under the level of 100pmol/L and P under the level of 2nmol/L. Symptoms may appear to be similar to the emergence of menopause, such as anxiety, depression, irritability, varying degrees of hot flashes and sweat, vaginal dryness, decreased libido, infertility and so on. POF is a complex etiological disease, making it an intractable disorder.

Most of the estrogen within the female body is secreted by the follicle cells of the ovaries. Premature ovarian failure leads to follicle development stagnation, resulting in reduction of follicles. The proliferation of connective tissue also results in estrogen deficiency, causing a series of clinical symptoms described.

Currently, treatment methods mainly use supplementary estrogen, which is only a temporary solution. As long-term application may cause a series of side effects such as malignant transformation, people are often looking for a permanent cure with no side effects.

Stem cell therapy brings hope for patients with premature ovarian failure. Stem cells are the cells with self-renewing and pluripotent functions. The stem cells can not only repair the tissue cells, but also regulate the immune function. The role of stem cells creates new cells regeneration treatment modalities for premature ovarian failure. Stem cell tends to reach the impaired tissues and organs, nourish and repair the lesion ovary cells in order to fulfill its recovery purpose. Many studies have shown that traditional Chinese medicine (TCM) can improve the overall condition of the body. It is helpful for increasing the survival rate of the transplanted stem cells, and make the cells act better. At ReLife, our doctors apply mesenchymal stem cells from the umbilical cord or autologous adipose tissue of patients and combine it with traditional Chinese medicine. We have achieved gratifying results of improving the quality of life for many patients. Although stem cell transplantation can be effective in the treatment of premature ovarian failure, early diagnosis and treatment are still required. Do not wait until the follicle cells have completely disappeared or are replaced by the connective tissue as it will miss the best treatment time and affect the effectiveness of stem cell treatment.

SOURCE ReLife International Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Spark Therapeutics Expands Leadership Team to Support Development and Commercialization of its Late-Stage Gene Therapy Pipeline
2. DiaVacss Immunotherapy Product for Treatment of Type 1 Diabetes Receives Orphan Drug Status Designation from the FDA
3. FEMA Search and Rescue Canine Receives Stem Cell Therapy So He Can Continue to Save Lives
4. Immunotherapy Offers New Hope for Cancer Patients: One Man’s Alternative Cancer Treatment Journey
5. ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS
6. West Coast Bird Dog Champion Returns to Competition Thanks to Stem Cell Therapy by Vet-Stem, Inc.
7. Leading Cancer Research Centers Team Up To Launch Biotech Startup Focused On Cancer Immunotherapy
8. Dr. Ross Rich of Cave Creek Equine Recently Presented the Outcome of 42 Horses with Stifle Injuries Treated with Vet-Stem Regenerative Cell Therapy
9. Study Suggests Non-Invasive Stereotactic Ablative Body Radiotherapy May Be Suitable Alternative to Surgery for Early-Stage Lung Cancer Patients
10. Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
11. Topical BioMedics' Topricin Foot Therapy Cream for Diabetics Now Available in Walgreens' Diabetic Section
Post Your Comments:
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
(Date:11/25/2015)... 2015 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... fireside chat discussion at the Piper Jaffray 27th Annual ... The discussion is scheduled for Wednesday, December 2, at ... A replay will be available for 14 days after ... Julie NormartVP, Corporate Communications and Business Development , BrewLife(858) ...
(Date:11/24/2015)... 2015  Asia-Pacific (APAC) holds the third-largest share ... The trend of outsourcing to low-cost locations is ... volume share for the region in the short ... in the CRO industry will improve. ... ), finds that the market earned revenues ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/19/2015)... 19, 2015  Although some 350 companies are actively ... a few companies, according to Kalorama Information. These include Roche ... the market share of the 6.1 billion-dollar molecular testing ... Market for Molecular Diagnostic s .    ... still controlled by one company and only a handful ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
Breaking Biology News(10 mins):